269 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
Download search resultsDownload the search results for:
"Expanded Access" [STUDY-TYPES] (269 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Conditions: Endometrial Cancer;   Colon Cancer
Intervention: Other: Tissue sample from tumor
2 Approved for marketing A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: trastuzumab-MCC-DM1
3 Available Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
Condition: Prostate Cancer
Intervention: Drug: [11C]Acetate
4 No longer available Aprotinin US Special Access Protocol
Condition: Postoperative Hemorrhage
Intervention: Drug: Aprotinin (Trasylol, BAYA0128)
5 Temporarily not available Clopidogrel Resistance and the Possibility of Its Affection
Condition: Coronary Artery Disease
Intervention: Drug: clopidogrel
6 No longer available Atazanavir for HIV Infected Individuals: An Early Access Program
Condition: HIV Infections
Intervention: Drug: Atazanavir (BMS-232632)
7 Approved for marketing Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
8 Temporarily not available A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
Condition: Healthy
Intervention: Drug: HX-1171
9 Temporarily not available Clofazamine in the Long Term Treatment of Leprosy, Phase III
Condition: Leprosy
Intervention: Drug: clofazamine
10 No longer available A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Open Label Treatment Access: Maraviroc
11 Available Expanded Access Protocol of Blinatumomab in Pediatric and Adolescent Subjects With Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Condition: Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: Blinatumomab
12 Approved for marketing Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Condition: Iron Overload
Intervention: Drug: deferiprone
13 No longer available Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
Condition: Non-small Cell Lung Cancer
Intervention: Biological: Lucanix® (belagenpumatucel-L)
14 Available Accuracy and Reliability of GSA for Remnant Liver Function
Condition: Both Benign and Malignant Liver Mass
Intervention: Device: 99mTc-GSA
15 Available Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4-Diaminopyridine
16 Available Keratoconus and Ectasia Treatment Plan
Conditions: Keratoconus;   Ectasia
Interventions: Other: Riboflavin Solution;   Device: UV-X Illumination System
17 No longer available Treatment Protocol of Replagal for Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: agalsidase alfa
18 No longer available Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
Condition: Liver Failure
Intervention: Device: ELAD®
19 No longer available Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Condition: Renal Failure
Intervention: Biological: Biological/Vaccine: Enriched Hematopoetic Stem Cell Transplant
20 No longer available Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
Condition: Lung Transplant
Intervention: Drug: Cyclosporine Inhalation Solution

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years